Globally profiling sialylation status of macrophages upon statin treatment

Glycobiology

Volumn 25, Issue 9, 2015, Pages 1007-1015

  Wang, Dan ^a   Nie, Huan ^b   Ozhegov, Evgeny ^c   Wang, Lin ^a   Zhou, Aimin ^a   Li, Yu ^b   Sun, Xue Long ^a  

^a Cleveland State University   (United States)

^b HARBIN INSTITUTE OF TECHNOLOGY   (China)

^c CLEVELAND STATE UNIVERSITY   (United States)

Author keywords

Confocal microscopy; Flow cytometry; LC MS MS; Macrophage; Sialic acid

Indexed keywords

ATORVASTATIN; SIALIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; N ACETYLNEURAMINIC ACID;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL LYSATE; CELL SURFACE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FLOW CYTOMETRY; LIQUID CHROMATOGRAPHY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SIALYLATION; TANDEM MASS SPECTROMETRY; ANIMAL; CELL LINE; CELL MEMBRANE; DRUG EFFECTS; METABOLISM; MOUSE;

ANIMALS; ATORVASTATIN CALCIUM; CELL LINE; CELL MEMBRANE; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MACROPHAGES; MICE; N-ACETYLNEURAMINIC ACID;

EID: 84943255872     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwv038     Document Type: Article

References (48)

1. Aikawa M, Rabkin E, Sugiyama S, Voglic SJ, Fukumoto Y, Furukawa Y, Shiomi M, Schoen FJ, Libby P. 2001. An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro. Circulation. 103: 276-283.
2. Angata T, Varki A. 2002. Chemical diversity in the SAs and related alpha-keto acids: An evolutionary perspective. Chem Rev. 102:439-469.
3. Arquint M, Roder J, Chia LS, Down J, Wilkinson D, Bayley H, Braun P, Dunn R. 1987. Molecular cloning and primary structure of myelinassociated glycoprotein. Proc Natl Acad Sci USA. 84:600-604.
4. Bagriaçik EU, Miller KS. 1999. Cell surface SA and the regulation of immune cell interactions: The neuraminidase effect reconsidered. Glycobiology. 9:267-275.
5. Bayer NB, Schubert U, Sentürk Z, Rudloff S, Frank S, Hausmann H, Geyer H, Geyer R, Preissner KT, Galuska SP. 2013. Artificial and natural SA precursors influence the angiogenic capacity of human umbilical vein endothelial cells. Molecules. 18:2571-2586.
6. Bilyy RO, Antonyuk VO, Stoika RS. 2004. Cytochemical study of role of alpha-d-mannose-and beta-d-galactose-containing glycoproteins in apoptosis. J Mol Histol. 35:829-838.
7. Chen X, Varki A. 2010. Advances in the biology and chemistry of SAs. ACS Chem Biol. 5:163-176.
8. Cowing C, Chapdelaine JM. 1983. T cells discriminate between Ia antigens expressed on allogeneic accessory cells and B cells: A potential function for carbohydrate side chains on Ia molecules. Proc Natl Acad Sci USA. 80:6000-6004.
9. Crespo HJ, Lau JT, Videira PA. 2013. Dendritic cells: A spot on sialic Acid. Front Immunol. 4:491.
10. Crocker PR, Gordon S. 1986. Properties and distribution of a lectin-like hemagglutinin differentially expressed by murine stromal tissue macrophages. J Exp Med. 164:1862-1875.
11. Crocker PR, Mucklow S, Bouckson V, McWilliam A, Willis AC, Gordon S, Milon G, Kelm S, Bradfield P. 1994. Sialoadhesin, a macrophage SA binding receptor for haemopoietic cells with 17 immunoglobulin-like domains. EMBO J. 13:4490-4503.
12. Croons V, De Meyer I, Houten SM, Martinet W, Bult H, Herman AG, De Meyer GR. 2010. Effect of statins on the viability of macrophages and smooth muscle cells. J Cardiovasc Pharmacol. 55:269-275.
13. Dall'Olio F. 2000. The sialyl-alpha2,6-lactosaminyl-structure: biosynthesis and functional role. Glycoconj J. 17:669-676.
14. Eguchi H, Ikeda Y, Ookawara T, Koyota S, Fujiwara N, Honke K, Wang PG, Taniguchi N, Suzuki K. 2005. Modification of oligosaccharides by reactive oxygen species decreases sialyl lewis x-mediated cell adhesion. Glycobiology. 15:1094-1101.
15. Franz S, Frey B, Sheriff A, Gaipl US, Beer A, Voll RE, Kalden JR, Herrmann M. 2006. Lectins detect changes of the glycosylation status of plasma membrane constituents during late apoptosis. Cytometry A. 69:230-239.
16. Franz S, Herrmann K, Fürnrohr BG, Sheriff A, Frey B, Gaipl US, Voll RE, Kalden JR, Jäck HM, Herrmann M. 2007. After shrinkage apoptotic cells expose internal membrane-derived epitopes on their plasma membranes. Cell Death Differ. 14:733-742.
17. Frohman M, Cowing C. 1985. Presentation of antigen by B cells: Functional dependence on radiation dose, interleukins, cellular activation, and differential glycosylation. J Immunol. 134:2269-2275.
18. Galuska SP, Geyer H, Mink W, Kaese P, Kühnhardt S, Schäfer B, Mühlenhoff M, Freiberger F, Gerardy-Schahn R, Geyer R. 2012. Glycomic strategy for efficient linkage analysis of di-, oligo-and polySAs. J Proteomics. 75:5266-5278.
19. Gorczyca W, Wieczorek Z, Lisowski J. 1989. Cell surface SA affects immunoglobulin binding to macrophages. FEBS Lett. 259:99-102.
20. Hara S, Yamaguchi M, Takemori Y, Furuhata K, Ogura H, Nakamura M. 1989. Determination of mono-O-acetylated N-acetylneuraminic acids in human and rat sera by fluorometric high-performance liquid chromatography. Anal Biochem. 179:162-166.
21. Hartnell A, Steel J, Turley H, Jones M, Jackson DG, Crocker PR. 2001. Characterization of human sialoadhesin, a SA binding receptor expressed by resident and inflammatory macrophage populations. Blood. 97:288-296.
22. Heyder P, Gaipl US, Beyer TD, Voll RE, Kern PM, Stach C, Kalden JR, Herrmann M. 2003. Early detection of apoptosis by staining of acid-treated apoptotic cells with FITC-labeled lectin from Narcissus pseudonarcissus. Cytometry A. 55:86-93.
23. Huang KC, Chen CW, Chen JC, Lin WW. 2003. HMG-CoA reductase inhibitors inhibit inducible nitric oxide synthase gene expression in macrophages. J Biomed Sci. 10:396-405.
24. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH. 1994. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 84: 1415-1420.
25. Lehmann F, Tiralongo E, Tiralongo J. 2006. SA-specific lectins: Occurrence, specificity and function. Cell Mol Life Sci. 63:1331-1354.
26. Liang SL, Liu H, Zhou A. 2006. Lovastatin-induced apoptosis in macrophages through the Rac1/Cdc42/JNK pathway. J Immunol. 177:651-656.
27. Liu Z, Swindall AF, Kesterson RA, Schoeb TR, Bullard DC, Bellis SL. 2011. ST6Gal-I regulates macrophage apoptosis via α2-6 sialylation of the TNFR1 death receptor. J Biol Chem. 286:39654-39662.
28. Matsumoto M, Einhaus D, Gold ES, Aderem A. 2004. Simvastatin augments lipopolysaccharide-induced proinflammatory responses in macrophages by differential regulation of the c-Fos and c-Jun transcription factors. J Immunol. 172:7377-7384.
29. Meesmann HM, Fehr EM, Kierschke S, Herrmann M, Bilyy R, Heyder P, Blank N, Krienke S, Lorenz HM, Schiller M. 2010. Decrease of SA residues as an eat-me signal on the surface of apoptotic lymphocytes. J Cell Sci. 123:3347-3356.
30. Morimoto N, Nakano M, Kinoshita M, Kawabata A, Morita M, Oda Y, Kuroda R, Kakehi K. 2001. Specific distribution of SAs in animal tissues as examined by LC-ESI-MS after derivatization with 1,2-diamino-4,5-methylenedioxybenzene. Anal Chem. 73:5422-5428.
31. Morris RG, Hargreaves AD, Duvall E, Wyllie AH. 1984.Hormone-induced cell death. 2. Surface changes in thymocytes undergoing apoptosis. Am J Pathol. 115:426-436.
32. Pahan K, Sheikh FG, Namboodiri AM, Singh I. 1997. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J Clin Invest. 100:2671-2679.
33. Peter ME, Hellbardt S, Schwartz-Albiez R, Westendorp MO, Walczak H, Moldenhauer G, Grell M, Krammer PH. 1995. Cell surface sialylation plays a role in modulating sensitivity towards APO-1-mediated apoptotic cell death. Cell Death Differ. 2:163-171.
34. Rapoport E, Pendu JL. 1999. Glycosylation alterations of cells in late phase apoptosis from colon carcinomas. Glycobiology. 9:1337-1345.
35. Schauer R. 2000. Achievements and challenges of SA research. Glycoconj J. 17:485-499.
36. Simmons D, Seed B. 1988. Isolation of a cDNA encoding CD33, a differentiation antigen of myeloid progenitor cells. J Immunol. 141:2797-2800.
37. Stamenkovic I, Seed B. 1990. The B-cell antigen CD22 mediates monocyte and erythrocyte adhesion. Nature. 345:74-77.
38. Swindall AF, Bellis SL. 2011. Sialylation of the Fas death receptor by ST6Gal-I provides protection against Fas-mediated apoptosis in colon carcinoma cells. J Biol Chem. 286:22982-22990.
39. Takashima S. 2008. Characterization of mouse sialyltransferase genes: Their evolution and diversity. Biosci Biotechnol Biochem. 72:1155-1167.
40. Takemoto M, Liao JK. 2001. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol. 21:1712-1719.
41. Varki A, Angata T. 2006. Siglecs-the major subfamily of I-type lectins. Glycobiology. 16:1R-27R.
42. Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME. 2009. Essentials of Glycobiology. 2nd ed. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press.
43. Varki NM, Varki A. 2007. Diversity in cell surface SA presentations: Implications for biology and disease. Lab Invest. 87:851-857.
44. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. 1995. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods. 184:39-51.
45. Videira PA, Amado IF, Crespo HJ, Algueró MC, Dall'Olio F, Cabral MG, Trindade H. 2008. Surface alpha 2-3-and alpha 2-6-sialylation of human monocytes and derived dendritic cells and its influence on endocytosis. Glycoconj J. 25:259-268.
46. Youssef S, Stüve O, Patarroyo JC, Ruiz PJ, Radosevich JL, Hur EM, Bravo M, Mitchell DJ, Sobel RA, Steinman L, et al. 2002. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature. 420:78-84.
47. Zhuo Y, Bellis SL. 2011. Emerging role of alpha2,6-sialic acid as a negative regulator of galectin binding and function. J Biol Chem. 286: 5935-5941.
48. Zhuo Y, Chammas R, Bellis SL. 2008. Sialylation of beta1 integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis. J Biol Chem. 283:22177-22185.